関連する実験動画
Updated: Jul 11, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
高活性抗レトロウイルス治療が,口内の発生頻度に与える影響
D Greenspan1, A J Canchola, L A MacPhail
1Department of Stomatology and the Oral AIDS Center, University of California at San Francisco, San Francisco, CA, USA. dgre@itsa.ucsf.edu
Lancet (London, England)
|May 18, 2001
まとめ
高活性抗レトロウイルス療法 (HAART) は,口腔カンジドーシスおよびカポシ肉腫の減少と,口腔の増加に関連しています. この研究は,口内がHAARTの合併症である可能性があることを示唆しています.
科学分野:
- 口腔医学は,口腔医学というものです.
- 感染症 感染症は感染症です.
- HIV/AIDSに関する研究 HIV/AIDSに関する研究
背景:
- 高活性抗レトロウイルス療法 (HAART) は,HIV/AIDSの管理に変革をもたらしました.
- 口腔疾患のパターンの変化は,HIV治療の進化とともに起こり得る.
研究 の 目的:
- HAARTを受けている患者の口腔疾患の進化パターンを調査する.
- 特定の口腔病変とHAART,免疫機能,ウイルス負荷との関連性を決定する.
主な方法:
- 1990年7月から1999年6月にかけて,HIV陽性患者1280人を対象とした遡及的研究.
- 口服の発見は,薬の使用,CD4カウント,ウイルス負荷と相関していました.
- 9年間の病気の頻度の分析.
主要な成果:
- 口腔カンジドーシス,毛深い白血球症,カポシ肉腫の有意な減少が観察されました.
- アフトス性潰瘍の発生率に有意な変化はありません.
- 唾液腺疾患の罹患率の増加と,HAART患者の間で口内の6倍の増加 (p=0.01).
結論:
- 口腔疾患のパターンは,HAARTの出現とともに変化しました.
- 口内はHAARTの潜在的な合併症であり,さらなる調査が必要である.
- 抗レトロウイルス治療を受けている患者にとって,口腔衛生のモニタリングは依然として重要である.
関連する概念動画
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

